Researchers have successfully develop single-atom editing technology that maximizes drug efficacy.

As bacterial resistance continues to evolve, the quest for new antimicrobial agents has gained urgency. Metal complexes have ...

With the Oct. 5 deadline come and gone, the West Virginia First Foundation received a total of 174 grant applications for ...

Difficult. Impossible. Agonizing. Worse than voting in the national election. | Difficult. Impossible. Agonizing. Worse than ...

It is that time of the year when many federal employees as well as retirees must make some important decisions regarding ...

Researchers develop single atom-engineered antibiotics using graphene and manganese ions, offering a new solution to tackle ...

The FDA decision will enable Antag Therapeutics to initiate the clinical development of its lead candidate drug, a ...

Magdalena aiming to submit Investigational New Drug (IND) application in early 2025 to the FDA for a next-generation psychoactive prescription drug candidate for potential mental health indications ...

AI-based clinical simulation systems can be a game-changer for the pharmaceutical industry. The ability to predict clinical ...

CLD-101 is a novel stem cell-based treatment that delivers oncolytic viruses to tumors, which may benefit patients with newly ...

In its new drug application, Stealth BioTherapeutics described elamipretide as a first-in-class mitochondrial protective ...

Bayer announced today that the FDA has accepted their new drug application (NDA) for menopause drug, elinzanetant, to treat ...